SCHEMBL24310412

SCHEMBL24310412

CC(C)Oc1c(Cl)nc(NSc2cnn(C)c2)nc1Cl

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 1/20 0.32
▸ TTK P33981 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309390 0.84 JAK2 (0.31) —
SCHEMBL24310652 0.83 KDM5B (0.30) —
SCHEMBL24310706 0.82 ALDH1A1 (0.33) —
SCHEMBL24309898 0.80 ALDH1A1 (0.31) —
SCHEMBL24310222 0.77 KDM5B (0.30) —
SCHEMBL24309878 0.76 PIK3CD (0.34) —
SCHEMBL24310692 0.73 JAK2 (0.33) —
SCHEMBL24309818 0.72 HTR1A (0.36) —
SCHEMBL24310591 0.71 PDE10A (0.31) —
SCHEMBL24309723 0.69 JAK2 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback